Sarcoglycan-β rabbit pAb
ENT-A3659
Description
| REF | ENT-A3659 |
|---|---|
| Category | Antibody Polyclonal |
| Description | Sarcoglycan-β rabbit pAb |
| Source | Rabbit |
| Applications | WB;IHC;IF;ELISA |
| Reactivity | Human;Mouse |
| Reactivity | Human;Mouse |
| Dilution | Western Blot: 1/500 – 1/2000. Immunohistochemistry: 1/100 – 1/300. ELISA: 1/40000. Not yet tested in other applications. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human Sarcoglycan-beta. AA range:87-136 |
| Storage Stability | -20°C/1 year |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1 mg/ml |
| Observed Band KD | 43kD |
| Human Gene ID | 6443 |
| Human Swiss Prot Nº | Q16585 |
| Subcellular Location | Cell membrane, sarcolemma ; Single-pass type II membrane protein . Cytoplasm, cytoskeleton . |
Other Name: SGCB; Beta-sarcoglycan; Beta-SG; 43 kDa dystrophin-associated glycoprotein; 43DAG; A3b
Background: This gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008],
